Met Life Investment Management, LLC Intellia Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $16.6 Billion
- Q2 2024
A detailed history of Met Life Investment Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 55,696 shares of NTLA stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
55,696
Previous 46,496
19.79%
Holding current value
$1.17 Million
Previous $1.28 Million
2.58%
% of portfolio
0.01%
Previous 0.01%
Shares
51 transactions
Others Institutions Holding NTLA
# of Institutions
326Shares Held
88.8MCall Options Held
673KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$244 Million2.36% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$202 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$191 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$101 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$91.7 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.6B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...